Despite a pause in U.S. tariffs, there is looming uncertainty and concern about how a potential trade war could hit Canada’s medicine supplies.
Canada has been given a 30-day reprieve from U.S. tariffs threatened by President Donald Trump, but that has done little to allay fears in the pharmaceutical realm.
“I think there’s a concern here that any sort of tariff war on this space could send ripples throughout the supply chain,” said Mina Tadrous, an assistant professor at the University of Toronto’s Leslie Dan Faculty of Pharmacy.
Tadrous told Global News the concern stems from the fact that the supply chain for medications is so global that the production of each drug crosses multiple borders before Canadians get the finished product from their local pharmacy.
“So, the structure of how tariffs work can have [an] add-on effect to how the drug pricing works,” he said.
More News
Image
Welcoming Ivy Lam as Academic Lead in Climate, Health & Sustainable Care
Assistant Professor Lam will guide the Leslie Dan Faculty of Pharmacy's efforts to embed environmental sustainability across the Faculty.
Read More
Image
Pharmacy alum’s research shows how full-scope practice improves cancer care
Honoured with a national award, Adrian de Boer says his residency experience was a powerful reminder that he's making a meaningful change to the pharmacy profession.
Read More
Image
Pharmacy alum passionate about helping community pharmacists practice to full scope
As a pharmacy leader at Rexall, Heidi Wittke uses frontline experience to lead initiatives that improve patient care
Read More